The oxygen therapy devices market size was valued at USD 39.09 billion in 2025 and is projected to grow from USD 41.55 billion in 2026 to USD 69.59 billion by 2034 at a CAGR of 6.66% during the forecast period (2026-2034). North America dominated the oxygen therapy devices market with a market share of 38.5% in 2025.
Oxygen therapy devices are medical equipment designed to deliver supplemental oxygen to patients experiencing respiratory disorders or low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, masks, and nasal cannulas used in hospitals, clinics, emergency care, and home healthcare settings. Demand is driven by the rising prevalence of chronic respiratory diseases, an aging population, increasing home-based care, and advancements in portable oxygen delivery technologies.
Download a Free Sample To learn more about this report,
Growing Adoption of Portable and Home-Based Oxygen Therapy Solutions
Oxygen Therapy Devices Market trends are being driven by the increasing preference for home healthcare and portable respiratory support devices. The rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis, along with the growing elderly population, is encouraging patients to shift toward home-based oxygen therapy. Manufacturers are introducing compact oxygen concentrators with longer battery life, quieter operation, and improved mobility, allowing patients to maintain active lifestyles while receiving continuous oxygen support. These developments are supporting oxygen therapy devices market growth by expanding access to convenient and long-term respiratory care.
Rising Innovation in Smart Oxygen Delivery and Connected Respiratory Care
Oxygen Therapy Devices Market trends are also being influenced by the integration of digital health technologies into respiratory care devices. Manufacturers are incorporating remote monitoring, Bluetooth connectivity, cloud-based patient data management, and AI-enabled performance tracking to improve therapy adherence and clinical outcomes. These smart features allow healthcare providers to monitor patients remotely and optimize oxygen delivery based on individual treatment needs. Such technological advancements are strengthening oxygen therapy devices market share by improving patient convenience, reducing hospital visits, and supporting the growing adoption of connected respiratory care solutions.
Rising Burden of Respiratory Diseases and Expanding Home Healthcare
The oxygen therapy devices market is experiencing steady growth due to the increasing prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and sleep apnea. The growing elderly population, rising air pollution, and increasing demand for home-based healthcare are encouraging the adoption of oxygen concentrators, cylinders, and portable oxygen delivery systems. Healthcare providers are also focusing on improving long-term respiratory care, further strengthening oxygen therapy devices market demand across hospitals, clinics, and home care settings.
High Equipment Costs and Limited Access in Developing Regions
The oxygen therapy devices market faces restraints due to the high cost of advanced oxygen delivery systems and the ongoing maintenance required for these devices. Many healthcare providers and patients in low- and middle-income countries continue to face affordability challenges, limiting access to modern oxygen therapy equipment. In addition, inadequate healthcare infrastructure and inconsistent oxygen supply networks in certain regions can affect product adoption and long-term usage.
Technological Advancements in Portable and Smart Oxygen Delivery Systems
The oxygen therapy devices market offers significant opportunities through the development of lightweight, portable, and digitally connected oxygen therapy solutions. Manufacturers are introducing smart oxygen concentrators equipped with remote monitoring, battery optimization, and real-time performance tracking to improve patient convenience and treatment outcomes. Growing investments in home healthcare technologies and telehealth integration are also expected to strengthen oxygen therapy devices market share by supporting personalized respiratory care.
Ensuring Reliable Oxygen Supply and Regulatory Compliance
The oxygen therapy devices market continues to face challenges in maintaining reliable oxygen delivery while meeting evolving regulatory and quality standards. Manufacturers must ensure device accuracy, durability, and patient safety while addressing supply chain disruptions and rising production costs. At the same time, healthcare providers require continuous technical support, regular device maintenance, and trained personnel to ensure effective long-term oxygen therapy. Meeting these requirements demands ongoing investment in product innovation, manufacturing efficiency, and service infrastructure.
Request Customizationto receive a tailored report.
Oxygen Source Equipment Segment Dominated the Market with 68.4% Share in 2025
The oxygen source equipment segment dominated the global oxygen therapy devices market with a 68.4% share in 2025, driven by the increasing prevalence of chronic respiratory disorders and the growing demand for reliable long-term oxygen therapy. The widespread use of oxygen generation and storage devices across hospitals, emergency care settings, and home healthcare continues to strengthen the segment's leading position.
The oxygen delivery devices segment is witnessing steady growth as healthcare providers increasingly adopt advanced delivery systems to improve patient comfort and treatment efficiency. Rising demand for personalized oxygen therapy, coupled with the growing aging population and increasing incidence of respiratory illnesses, continues to support the expansion of this segment.
Continuous technological advancements in portable oxygen systems, smart monitoring capabilities, and energy-efficient devices are expected to further accelerate market growth. Increasing investments in respiratory care infrastructure and home-based treatment solutions continue to create opportunities across both product categories.
Oxygen Concentrators Segment Dominated the Market with 39.8% Share in 2025
The oxygen concentrators segment dominated the oxygen source equipment market with a 39.8% share in 2025, owing to their ability to provide a continuous oxygen supply without frequent refilling. Their ease of use, lower operating costs, and growing adoption in home healthcare settings have made them the preferred choice for long-term oxygen therapy.
The oxygen cylinders and PAP devices segments are witnessing steady growth as healthcare facilities continue to rely on cylinders for emergency oxygen supply while the increasing prevalence of sleep-related breathing disorders is driving demand for PAP devices. At the same time, liquid oxygen devices are gaining wider acceptance among patients requiring high-flow oxygen therapy due to their portability and higher oxygen storage capacity.
Within oxygen cylinders, fixed cylinders continue to account for the larger share because of their extensive use in hospitals and healthcare facilities, while portable cylinders are gaining popularity for ambulatory patients. In oxygen concentrators, fixed units remain widely used for continuous therapy, whereas portable concentrators are expanding rapidly due to their lightweight design and greater patient mobility. Among PAP devices, CPAP continues to lead the segment, while APAP is witnessing faster adoption because of its automatic pressure adjustment capabilities, and Bi-PAP devices remain an important option for patients requiring advanced respiratory support.
Nasal Cannula Segment Dominated the Market with 27.4% Share in 2025
The nasal cannula segment dominated the oxygen delivery devices market with a 27.4% share in 2025, driven by its high patient comfort, ease of use, and suitability for long-term oxygen therapy. Its widespread adoption across hospitals, outpatient facilities, and home healthcare continues to support the segment's leading position.
The oxygen masks, Venturi masks, and CPAP masks segments are witnessing steady growth due to increasing demand for controlled oxygen delivery across different clinical conditions. Meanwhile, non-rebreather masks and bag valve masks continue to play an essential role in emergency medicine and critical care, where rapid oxygen administration is required.
The others segment is also expanding steadily as manufacturers introduce specialized oxygen delivery interfaces designed for pediatric care, high-flow oxygen therapy, and patient-specific clinical needs. Ongoing innovations focused on improving patient comfort, oxygen efficiency, and ease of use are expected to support growth across all oxygen delivery device categories.
Chronic Obstructive Pulmonary Disease Segment Dominated the Market with 34.2% Share in 2025
The chronic obstructive pulmonary disease (COPD) segment dominated the global oxygen therapy devices market with a 34.2% share in 2025, supported by the growing prevalence of chronic respiratory disorders and the increasing need for long-term oxygen therapy. Rising aging populations, smoking-related illnesses, and improved diagnosis rates continue to drive demand for oxygen therapy devices in COPD management.
The obstructive sleep apnea, asthma, and pneumonia segments are witnessing steady growth as awareness of respiratory health increases and more patients receive timely diagnosis and treatment. Growing adoption of PAP devices and home oxygen therapy solutions is contributing significantly to the expansion of these application areas.
The respiratory distress syndrome, cystic fibrosis, and others segments are also growing steadily due to rising demand for specialized respiratory care across neonatal, pediatric, and adult patient populations. Continuous improvements in respiratory support technologies and expanding access to advanced healthcare services are expected to sustain long-term growth across these applications.
Home Healthcare Segment Dominated the Market with 61.3% Share in 2025
The home healthcare segment dominated the global oxygen therapy devices market with a 61.3% share in 2025, driven by the increasing preference for home-based treatment among patients with chronic respiratory diseases. Growing availability of portable oxygen therapy devices, reduced hospitalization costs, and improving reimbursement support continue to strengthen demand in this segment.
The non-home healthcare segment is witnessing steady growth as hospitals, specialty clinics, rehabilitation centers, and emergency care facilities continue to invest in advanced respiratory care equipment. Rising hospital admissions related to respiratory illnesses and the need for continuous oxygen support remain key factors supporting this segment.
Increasing healthcare infrastructure development, technological advancements in respiratory devices, and the growing burden of chronic lung diseases are expected to create sustained demand across both home and non-home healthcare settings, supporting the overall expansion of the market.
Speak to an Analystto discuss market opportunities.
North America oxygen therapy devices market accounted for 38.5% of the global market, reaching USD 15.05 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. Rising prevalence of chronic respiratory diseases, increasing demand for home healthcare, and growing adoption of portable oxygen delivery systems continue to drive regional market growth. Expanding healthcare infrastructure and favorable reimbursement policies are also supporting market expansion.
The U.S. market was valued at USD 12.79 billion in 2025, making it the largest contributor in North America. Growing cases of chronic obstructive pulmonary disease (COPD), increasing aging population, and rising demand for home-based respiratory care continue to strengthen market growth.
Canada's market reached USD 2.26 billion in 2025. Increasing awareness of respiratory health, expanding healthcare services, and growing adoption of advanced oxygen therapy devices continue to support steady market expansion.
Europe oxygen therapy devices market accounted for 27.4% of the global market, reaching USD 10.71 billion in 2025, and is expected to register a CAGR of 6.5% during the forecast period. Increasing prevalence of respiratory disorders, rising healthcare expenditure, and growing demand for long-term oxygen therapy are driving regional growth. Continuous investments in advanced medical technologies further support market development.
Germany's market accounted for USD 3.11 billion in 2025. Strong healthcare infrastructure, increasing adoption of home oxygen therapy, and growing elderly population continue to support market growth.
The UK market was valued at USD 2.14 billion in 2025. Rising demand for respiratory care services, expanding home healthcare programs, and increasing healthcare investments continue to contribute to market expansion.
Asia Pacific oxygen therapy devices market accounted for 22.8% of the global market, valued at USD 8.91 billion in 2025, and is projected to register a CAGR of 8.9% during the forecast period. Expanding healthcare infrastructure, increasing incidence of respiratory diseases, growing geriatric population, and rising awareness of home healthcare continue to accelerate regional market growth.
Japan's market generated USD 1.60 billion in 2025. Rising demand for respiratory care, increasing adoption of advanced oxygen concentrators, and a growing elderly population continue to support market growth.
China's market accounted for USD 4.63 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare facilities, increasing prevalence of chronic respiratory conditions, and growing demand for affordable oxygen therapy devices continue to drive market expansion.
Latin America oxygen therapy devices market accounted for 6.1% of the global market, reaching USD 2.38 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. Improving healthcare infrastructure, increasing awareness of respiratory disease management, and rising demand for home healthcare equipment continue to support regional market growth.
Brazil's market reached USD 1.21 billion in 2025. Growing healthcare investments, expanding access to respiratory care, and increasing adoption of oxygen therapy devices continue to create growth opportunities across the country.
Middle East & Africa oxygen therapy devices market accounted for 5.2% of the global market, totaling USD 2.03 billion in 2025, and is anticipated to grow at a CAGR of 6.9% during the forecast period. Rising healthcare investments, increasing prevalence of respiratory diseases, and expanding hospital infrastructure are supporting regional market growth.
The UAE market was valued at USD 0.73 billion in 2025. Government investments in advanced healthcare infrastructure, increasing demand for respiratory care solutions, and growing adoption of home oxygen therapy continue to drive market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com